We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are OK with this.     OK  No, I would like to know more...
Home / About Novasep / Media & Events / Case studies

Case studies

Advanced Antibody Drug Conjugate characterization

02 Aug 2019

With 90% in-house analysis, Novasep’s QC experts have developed an internal platform method for fast ADC characterization. The method, presented in this case study, is now used for customer projects.


Successful process development, validation and commercial manufacturing of an ADC payload

02 Aug 2019

Novasep was approached by a top 10 pharmaceutical company looking for a reliable partner to manufacture an ADC payload. The product was in clinical trial Phase I to treat cancer, and the customer first required a validation at 100g scale with prior optimization of the initial medchem process.


Successful cGMP conjugation of a Novel ADC for phase I clinical trials

15 Feb 2018

Novasep was approached by a top 10 pharmaceutical company to help with the manufacture of a cGMP antibody drug conjugate. The ADC was in clinical trial Phase I to treat solid tumors, and the customer required a quantity of ADC within 4 months starting from 100g monoclonal antibody.



You can stay on this page and select more documents or you can directly download the brochure(s) you selected

Your brochure is ready!

X

You can stay on this page and select more documents or you can directly download the brochure(s) you selected

Give us your feedback!